Abstract
A number of dibenzocycloheptenone derivatives, a novel series of aldose reductase inhibitors, were synthesized and evaluated in vitro for their ability to inhibit rat lens aldose reductase enzyme. The design of these ARIs was based on previously published pharmacophore requirements. The most active compound in this series was a spirosuccinimide derivative, spiro{2,8- dihydroxy-5H-dibenzo[a, d]cycloheptene5,3'-pyrrolidine}-2',5'-dione 11, having an IC50 of 3.0 μM.
Original language | English (US) |
---|---|
Pages (from-to) | 399-404 |
Number of pages | 6 |
Journal | European Journal of Medicinal Chemistry |
Volume | 34 |
Issue number | 5 |
DOIs | |
State | Published - May 1999 |
Externally published | Yes |
Keywords
- Aldose reductase inhibitor
- Diabetic complications
- Dibenzocycloheptenone
ASJC Scopus subject areas
- Pharmacology
- Drug Discovery
- Organic Chemistry